Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mind Medicine (MindMed) Inc N.MMED


Primary Symbol: MNMD Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR

Healthcare Psychedelics
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

Recent & Breaking News (NDAQ:MNMD)

Broadway Drills Best Copper Hole to Date and Extends Copper Zone at Madison

MarketWire Canada July 11, 2017

Broadway Intercepts Additional Massive Sulfide Zone at Madison

MarketWire Canada June 28, 2017

Broadway Reports Continued Underground Drill Success at Madison: 1.098% Copper and 1.651 g/t Gold Over 25.3 Meters

MarketWire Canada June 15, 2017

Broadway Discovers New Gold Zone at Madison and Expands Native Copper Zone

MarketWire Canada May 18, 2017

Broadway Reports Continued Drill Success at Madison Underground: 41.6 g/t Gold Over 11 Meters

MarketWire Canada May 10, 2017

IIROC Trading Resumption - BRD

Canada NewsWire May 3, 2017

IIROC Trade Resumption - Broadway Gold Mining Ltd.

Newsfile May 3, 2017

Broadway Reports High-Grade Results of 99 Feet of 24.50 g/t Gold at Madison

MarketWire Canada May 3, 2017

IIROC Trading Halt - BRD

Canada NewsWire May 3, 2017

IIROC Trade Halt - Broadway Gold Mining Ltd.

Newsfile May 3, 2017

Broadway Announces Closing of Non-Brokered Private Placement Financing

MarketWire Canada April 28, 2017

Broadway Provides Private Placement Update

MarketWire Canada April 27, 2017

Broadway Gold Mining Announces $5,000,000 Non-Brokered Private Placement Financing

MarketWire Canada April 4, 2017

Broadway Announces Executive and Board Changes -- Names Parnham President and CEO

MarketWire Canada April 3, 2017

Broadway Quadruples Madison Copper-Gold Land Holdings

MarketWire Canada March 29, 2017

Broadway Announces Additional High-Grade Drill Results at Madison, Intercepts 168 Feet and 141 Feet Copper-Gold Sections

MarketWire Canada March 21, 2017

Broadway Board Member Burchill Resigns

MarketWire Canada March 17, 2017

Broadway IP Survey Identifies Potential Porphyry Targets at Madison

MarketWire Canada March 8, 2017

Broadway Reports High-Grade Drill Results in Upper Zone at Madison, Intercepts 156 Feet Copper-Gold

MarketWire Canada March 3, 2017

Broadway Adds Second Drill and Commences Phase I Underground Program at Madison Copper-Gold Project

MarketWire Canada February 27, 2017